Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Intervalo de año de publicación
1.
Front Immunol ; 12: 624736, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34054799

RESUMEN

Acute schistosomiasis (AS) manifests with a broad spectrum of clinical features in pediatric populations. Diagnosis may be difficult in the absence of detectable numbers of eggs. As a result, new approaches may be required to achieve an accurate diagnosis. Optimal praziquantel (PZQ) treatment regimen for young children is debatable. Also, the post-treatment response is still poorly evaluated due to the lack of reliable markers. A group of 6 children (a toddler and 5 pre-school children) and one pre-adolescent were investigated for AS clinical manifestations and followed-up for two years after treatment. Ova detection was performed by Kato-Katz (KK) and presence of Schistosoma mansoni DNA was assessed by real-time PCR (rt-PCR) in stool samples. IgG and IgE anti-Schistosoma levels and urinary antigen were detected by ELISA and point-of-care circulating cathodic antigen (POC-CCA) testing in serum and urine, respectively. AS clinical symptoms were present in 5/7 (71.4%) of the infected children, and hypereosinophilia was detected in all of them. Ova detection and serology were positive in only 3/7 (44.9%) and 4/7 (57.1%), respectively. However, real-time PCR (rt-PCR) showed the presence of Schistosoma DNA in 6/7 (85.7%) of the cases, and urinary antigen was detected in all infected children. The long-term follow-up after treatment with three doses of PZQ (80mg/kg/dose), showed high cure rates (CR) as demonstrated by the DNA-based assay as well as reduced levels of side effects. CR based on urinary antigen detection ranged from 28.6 to 100%, being the highest CR due to double testing the 2-year post-treatment samples. The results suggest that high dose and repeated treatment with PZQ might be effective for AS in young children. Also, new laboratory markers should be considered to diagnosis and monitor the drug response.


Asunto(s)
Antihelmínticos/uso terapéutico , Parasitología , Praziquantel/uso terapéutico , Schistosoma mansoni/efectos de los fármacos , Esquistosomiasis mansoni/diagnóstico , Esquistosomiasis mansoni/tratamiento farmacológico , Adolescente , Animales , Anticuerpos Antihelmínticos/sangre , Antígenos Helmínticos/orina , Biomarcadores/sangre , Biomarcadores/orina , Preescolar , ADN de Helmintos/genética , Ensayo de Inmunoadsorción Enzimática , Heces/parasitología , Femenino , Glicoproteínas/orina , Proteínas del Helminto/orina , Humanos , Inmunoglobulina E/sangre , Inmunoglobulina G/sangre , Lactante , Masculino , Recuento de Huevos de Parásitos , Pruebas en el Punto de Atención , Valor Predictivo de las Pruebas , Reacción en Cadena en Tiempo Real de la Polimerasa , Schistosoma mansoni/genética , Schistosoma mansoni/inmunología , Esquistosomiasis mansoni/parasitología , Pruebas Serológicas , Resultado del Tratamiento
2.
Case Rep Dermatol ; 6(1): 114-8, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24847249

RESUMEN

Sporotrichosis is a subacute or chronic mycosis caused by a fungus of the genus Sporothrix, which is found in soil. It can be acquired by trauma to the skin. Bone and joint lesions are very rare. The city of Rio de Janeiro is undergoing an epidemic transmitted by cats, and this should be an alert for the risk to professionals in contact with these animals. The patient was a veterinarian who developed occupational sporotrichosis with osteoarticular involvement transmitted by a cat during a consultation.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...